Patents by Inventor Josep Mas Prio

Josep Mas Prio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzoxazinone-derived compounds, their preparation and use as medicaments
    Patent number: 7514429
    Abstract: The present invention relates to Benzoxazinone-derived compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: April 7, 2009
    Assignee: ESTEVE Laboratorios Dr. Esteve S.A.
    Inventors: Antoni Torrens Jover, Jose Aurelio Castrillo Perez, Jordi Frigola Constansa, Josep Mas Prió, Alberto Dordal Zueras, Maria Angeles Fisas Escasany
  • 5-ht7 receptor antagonists
    Publication number: 20090088450
    Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.
    Type: Application
    Filed: August 18, 2005
    Publication date: April 2, 2009
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Albert Dordal Zueras, Lus Romero Alonso, Hulmut Henrich Buschmann
  • 5-Ht7 Receptor Antagonists
    Publication number: 20090036480
    Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylen substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.
    Type: Application
    Filed: December 27, 2005
    Publication date: February 5, 2009
    Inventors: Antoni Torrens Jover, Susana Yenes Minguez, Josep Mas Prio, Luz Romero Alonso, Alberto Dordal Zueras, Helmut Henrich Buschmann
  • 5-Ht7 Receptor Antagonists
    Publication number: 20080214603
    Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.
    Type: Application
    Filed: December 27, 2005
    Publication date: September 4, 2008
    Inventors: Antoni Torrens Jover, Susana Yenes Minguez, Josep Mas Prio, Luz Romero Alonso, Alberto Dordal Zueras, Helmut Henrich Buschmann
  • 2-'4(Phenylamino)-Piperidin-1-Yl!-N-Phenyl-Acetamine Derivatives and Related Compounds as Neuropeptide Y5 (NPY5) Ligands for the Treatment of Obesity
    Publication number: 20080119516
    Abstract: It was an object of the present invention to provide novel compounds that are suitable in particular as active substances in medicaments, preferably in medicaments for the regulation of neuropeptide Y receptors, particularly preferably of neuropeptide Y5 (NPY5) receptor, for the regulation of food ingestion (food intake), preferably for the prophylaxis and/or treatment of disorders of food ingestion, such as obesity, anorexia, cachexia, bulimia or type II (non insulin dependent) diabetes, for the prophylaxis and/or treatment of disorders of the peripheral nervous system, disorders of the central nervous system, anxiety, depression, cognitive disorders, preferably memory disorders, cardiovascular diseases, pain, epilepsy, arthritis, hypertensive syndrom, inflammatory diseases, immune diseases and other NPY5 mediated disorders in animals and mammals, including man. Said object was achieved by providing 1,4-disubstituted piperidine compounds of general formula (I) wherein the substituents are defined in claim 1.
    Type: Application
    Filed: July 29, 2004
    Publication date: May 22, 2008
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Alberto Dordal Zueras, Maria Angeles Fisas Escasany
  • 2-'4-(Hydroxymethyl-phenylamino)-piperidine-1-yl!-n-(9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
    Publication number: 20070105853
    Abstract: The present invention relates to 1,4-disubstituted piperidine compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals. The substituents are as defined in the present claim 1.
    Type: Application
    Filed: July 29, 2004
    Publication date: May 10, 2007
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Alberto Dordal Zueras, Maria Fisas Escasany, Helmut-Heinrich Buschmann
  • 5-HTreceptor antagonists
    Patent number: 7211585
    Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: May 1, 2007
    Assignee: Laboratorios del Dr. Esteve, S.A.
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut H. Buschmann
  • 5-HT7 receptor ligands
    Patent number: 7211584
    Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: May 1, 2007
    Assignee: Laboratorios del Dr. Esteve, S.A.
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut H. Buschmann
  • Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
    Publication number: 20070059364
    Abstract: The present invention relates to an active substance combination comprising at least one compound with neuropeptide Y-receptor affinity and at least one compound with 5-HT6 receptor affinity, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.
    Type: Application
    Filed: July 29, 2004
    Publication date: March 15, 2007
    Applicant: Laboratorios Del Dr. Esteve S.A.
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Alberto Dordal Zueras, Xavier Codony Soler, Ramon Merce Vidal, Jose-Aurello Castrillo Perez, Jordi Frigola Constansa, Helmut-Heinrich Buschmann
  • Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
    Publication number: 20070032482
    Abstract: The present invention relates to benzoxazinone-derived sulphonamide compounds of general formula (I), a process for their preparation, a medicament comprising these compounds and the use of benzoxazinone-derived sulphonamide compounds for the preparation of medicaments for 5-HT6 receptor regulation as well as for the treatment of disorders related thereto.
    Type: Application
    Filed: July 29, 2004
    Publication date: February 8, 2007
    Applicant: Laboratorios Del Dr. Esteve S.A.
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Alberto Dordal Zueras, Maria Fisas Escasany
  • Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
    Publication number: 20070009597
    Abstract: The present invention relates to an active substance combination comprising at least one compound with neuropeptide Y-receptor affinity, preferably neuropeptide Y5-receptor affinity, and at least one compound with 5-HT6 receptor affinity, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.
    Type: Application
    Filed: July 29, 2004
    Publication date: January 11, 2007
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Albert Dordal Zueras, Xavier Codony Soler, Ramon Merce Vidal, Jose-Aurello Castillo Perez, Jordi Frigola Constansa, Helmut-Heinrich Buschmann
  • Benzoxazinone-derived compounds, their preparation and use as medicaments
    Patent number: 7056914
    Abstract: The present invention relates to Benzoxazinone-derived compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: June 6, 2006
    Assignee: ESTEVE Laboratorios Dr. Esteve S.A.
    Inventors: Antoni Torrens Jover, Jose Aurelio Castrillo Perez, Jordi Frigola Constansa, Josep Mas Prió, Alberto Dordal Zueras, Maria Angeles Fisas Escasany
  • 5-HT7 receptor ligands
    Publication number: 20060040977
    Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.
    Type: Application
    Filed: August 18, 2004
    Publication date: February 23, 2006
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut Buschmann
  • 5-HT7 receptor antagonists
    Publication number: 20060040978
    Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.
    Type: Application
    Filed: August 18, 2004
    Publication date: February 23, 2006
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut Buschmann
  • Benzoxazinone-derived compounds, their preparation and use as medicaments
    Publication number: 20040058920
    Abstract: The present invention relates to Benzoxazinone-derived compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals.
    Type: Application
    Filed: April 4, 2003
    Publication date: March 25, 2004
    Inventors: Antoni Torrens Jover, Jose Aurelio Castrillo Perez, Jordi Frigola Constansa, Josep Mas Prio, Alberto Dordal Zueras, Maria Angeles Fisas Escasany
  • 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same
    Patent number: 6355659
    Abstract: Antipsychotic compound 4-(4-chlorophenyl)-1,2,3,6-tetrahydro-1-[4-(1H-1,2,4-triazol-1-yl) butyl]pyridine, or one of its physiologically acceptable salts, pharmaceutical compositions containing those compounds and a method of treating a disease selected from psychosis and dementias in which a deficit of cognition predominates comprising administering to a patient in need of such treatment a therapeutically effective amount of the antipsychotic compound.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: March 12, 2002
    Assignee: Laboratorios Del Dr. Esteve, S.A.
    Inventors: Ramon Merce-Vidal, Jordi Frigola-Constansa, Blas Andaluz-Mataró, Josep Mas-Prió